ALERT: Due to the inclement weather across much of the country, Medtronic deliveries are currently experiencing delays and there will be longer than normal hold times on the phone. Visit www.Diabetes.shop if you need to place an order, get a sensor or belt clip replacement, or check the status of your supply order. X

Medicare Archive

New CGM Coverage for Medicare customers

We know that for those with Medicare coverage, it’s been long awaited to have the Medtronic integrated continuous glucose monitor (CGM) covered, and we’re thrilled to announce that the wait is over. Medicare has officially expanded to include CGMs that integrate with Medtronic insulin pumps. “This is a very important benefit expansion for our

CGM Medicare Access Next Steps: Contact Your Local Committee Members!

We’ve made great progress since re-introducing the Medicare CGM Access Act of 2015 (H.R. 1427, S 804), which would require Medicare to cover continuous glucose monitoring (CGM) for seniors who are currently denied access to this important diabetes management technology. Thanks to you, we now have 28 Senators and 153 House Members co-sponsoring the

Medicare CGM Access Act Of 2015: The Next Step To Reach Our Goal

For more than a year, Medtronic has been engaged in a coalition effort to support legislation that will expand coverage for diabetes therapies under Medicare. As you know, Medicare does not yet cover CGM devices, leaving seniors with diabetes without access to this technology. We have received a lot of customer feedback about this and

Update: Expanding Access To CGM In Medicare

It’s a new year, a new Congress, and a new opportunity to provide Continuous Glucose Monitoring (CGM) coverage for diabetes patients on Medicare! As we told you last year, Medtronic is engaged in a coalition effort to support legislation that will expand coverage for diabetes therapies under Medicare. Right now, Medicare does not cover CGM

Important Update on Medicare CGM Access Act

As most of you know, continuous glucose monitoring (CGM) technology is a valuable diabetes management tool clinically proven to provide better glucose control[1][2]. While 95% of private health plans cover the technology, Medicare does not, denying Americans age 65 and older access to this critical technology. For more than a year, Medtronic, along with